Pandox AB (publ) EBIT

The latest EBIT for PNDX-B.ST is $6.9B as of September 2026. That compares with $4.1B in the prior-year period — up 68.8% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Pandox AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, PNDX-B.ST's EBIT moved from $4.1B to $6.9B — a 68.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pandox AB (publ)'s operating scale or balance-sheet position.

Against its sector companies, PNDX-B.ST currently prints $6.9B for EBIT, while the sector average sits near $2.5T. That is roughly 99.7% below the sector mean. Large gaps often invite a closer look at Pandox AB (publ)'s growth, margins, and balance sheet.

A EBIT figure of $6.9B for PNDX-B.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting PNDX-B.ST's EBIT ($6.9B), review year-over-year change from $4.1B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.